Diffuse Large B-Cell Lymphoma Therapeutics Market Forecast to Reach $6.49 Billion by 2028 Amid Advancements in Personalized Medicine and Treatment Innovations
February 08, 2024 09:36 ET
|
Research and Markets
Dublin, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The "Diffuse Large B-cell Lymphoma Therapeutics Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. As the global community...
Leukemia Therapeutics Global Market Report 2023: Rises in Product Approvals and Increasing Diagnosis Awareness Drives Growth
May 02, 2023 07:33 ET
|
Research and Markets
Dublin, May 02, 2023 (GLOBE NEWSWIRE) -- The "Leukemia Therapeutics Market by Type, Drug Class, Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been...
Lymphoma Therapeutics Global Market to Reach $25.2 Billion by 2030: Artificial Intelligence Helps Speed up & Automate Lymphoma Diagnosis
April 12, 2023 12:43 ET
|
Research and Markets
Dublin, April 12, 2023 (GLOBE NEWSWIRE) -- The "Lymphoma Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Lymphoma...
Lymphoma Treatment Global Market Report 2022: Technological Advancements, Including the Development of Innovative Immune Checkpoint Inhibitors, Fuel Growth
October 26, 2022 09:43 ET
|
Research and Markets
Dublin, Oct. 26, 2022 (GLOBE NEWSWIRE) -- The "Lymphoma Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Worldwide Lymphoma Treatment Industry to 2026 - Featuring Abbott Laboratories, Novartis and Spectrum Pharmaceuticals Among Others
December 01, 2021 07:53 ET
|
Research and Markets
Dublin, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The "Lymphoma Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Global Non-Hodgkin Lymphoma (NHL) Therapeutics Markets, 2016-2020 & 2021-2026 by Type of Therapy, Cell Type, Drug Type, & Distribution Channel
September 28, 2021 04:33 ET
|
Research and Markets
Dublin, Sept. 28, 2021 (GLOBE NEWSWIRE) -- The "Global Non-Hodgkin Lymphoma (NHL) Therapeutics Market, By Type of Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Stem Cell Transplant,...
Global Chronic Lymphocytic Leukemia (CLL) Disorder Clinical Market Report 2021-2027
July 06, 2021 08:08 ET
|
Research and Markets
Dublin, July 06, 2021 (GLOBE NEWSWIRE) -- The "Chronic Lymphocytic Leukemia (CLL)" report has been added to ResearchAndMarkets.com's offering. Chronic lymphocytic leukemia (CLL) is a disorder where...
China Rituximab Market Report 2021-2025: A Monoclonal Antibody to Target Cells that have the CD20 Marker on their Surface
May 13, 2021 05:53 ET
|
Research and Markets
Dublin, May 13, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Rituximab Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. According to this market...
MMRGlobal Receives First Anti-CD20 Antibody and Online Medical Record Patents in Mexico
July 09, 2012 08:35 ET
|
MMRGlobal, Inc.
LOS ANGELES, CA--(Marketwire - Jul 9, 2012) - MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") today announced that it received Notices of Allowance for two additional biotech patents from the Mexican...